个人情况介绍、概览

金鹏飞，男，博士，教授。主任医师，博士生导师，北京医院药学部主任。主持国家自然科学基金、北京市自然科学基金、首都医学发展基金重点攻关等各类课题12项；完成成果转化1项。目前第一作者/通讯作者核心期刊发表论文200余篇（SCI论文近50篇）。

人才称号、社会兼职等（限填10项）

1.国家药典委员会委员

2.国家卫健委医院管理所药学信息专家委员会常务副主任委员

3.中国医药教育协会老年药学专委会主任委员

4.中国老年保健医学研究会药事管理与药学创新分会主任委员

5.中国药学会科学传播专委会副主任委员

6.中国中药协会合理用药专委会副主任委员

7.中国卫生经济学会青年卫生经济委员会常务委员

8.中国药学会医院药学专委会委员

9.《临床药物治疗杂志》、《中国药业》副主编

10.《中华老年医学杂志》、《中国药学杂志》、《药物分析杂志》、《中国药房》等11个核心期刊常务编委或编委。

主要研究方向（限填3项）

研究方向一：老年药学

研究方向二：药物安全性评价

研究方向三：药物分析

主持、参与的科研项目（含科研获奖等情况）（限填10项）

1. 2024.01-2026.12 北京市卫生健康委员会, 首都卫生发展科研专项重点攻关：心血管疾病常用中药与新型口服抗凝药物的相互作用研究体系构建及临床应用（首发2014-1-4052）,在研, 主持

2. 2023.11-2026.11国家卫生健康委医药卫生科技发展研究中心，创新药物上市后临床研究科研专项面上课题：基于大数据的中国慢病用药现状与合理性分析（WKZX2023CX210007），在研, 主持

近年来发表代表性论文(限第一作者或通讯作者，SCI须写明影响因子)：（限填10篇）

1.Yuanchao Zhu, Fei Zhao, Yubing Zhu, Xingang Li, Deshi Dong, Bolin Zhu, Jianchun Li, Xin Hu, Zinan Zhao, Wenfeng Xu, Yang Jv, Dandan Wang, Yingming Zheng, Yiwen Dong, Lu Li, Shilei Yang, Zhiyuan Teng, Ling Lu, Jingwei Zhu, Linzhe Du, Yunxin Liu, Lechuan Jia, Qiujv Zhang, Hui Ma, Ana Zhao, Hongliu Jiang, Xin Xu, Jinli Wang, Xuping Qian, Wei Zhang, Tingting Zheng, Chunxia Yang, Xuguang Chen, Kun Liu, Huanhuan Jiang, Dongxiang Qu, Jia Song, Hua Cheng, Wenfang Sun, Hanqiu Zhan, Xiao Li, Yafeng Wang, Aixia Wang, Li Liu, Lihua Yang, Nan Zhang, Shumin Chen, Jingjing Ma, Wei Liu, Xiaoxiang Du, Meiqin Zheng, Liyan Wan, Guangqing Du, Hangmei Liu, Pengfei Jin*. Real-world efficacy and safety of azvudine in hospitalized older patients with COVID-19 during the omicron wave in China: A retrospective cohort study. Acta Pharmaceutica Sinica B, 2025, 15(1):123-132. (IF=14.8)

2. Zinan Zhao, Fei Zhao, Yatong Zhang, Xin Hu, Jianchun Li, Chao Tian, Pengfei Jin*, Deping Liu*. Risk factors of dapagliflozin-associated diabetic ketosis/ketoacidosis in patients with type 2 diabetes mellitus: A matched case-control study. Diabetes Research and Clinical Practice, 2023, 196: 110236. doi:10.1016/j.diabres.2023.110236 (IF=6.1)

3. Xiang Wang, Wei Xu, Qirui Song, Zinan Zhao, Xuyang Meng, Chenxi Xia, Yibo Xie, Chenguang Yang, Pengfei Jin*, Fang Wang*. Association between the triglyceride–glucose index and severity of coronary artery disease. Cardiovascular Diabetology. 2022, 21:168. doi:10.1186/s12933-022-01606-5 (IF=9.3）

4.Tian Zhang, Ting Li, Pengfei Jin*. Global, regional, and national burden of cardiovascular disease attributable to kidney dysfunction (1990–2021) with projections to 2050: analysis of the 2021 Global Burden of Disease study. Renal Failure, 2025, 47:2472039, doi: 10.1080/0886022X.2025.2472039(IF=3.1)

5.Ting Li, Miaomiao Zhang, Tian Zhang, Shaoqiang Li, Chen Kou, Ming Zhao, Jing Huang, Weihang Cao, Pengfei Jin*. Cyclin-dependent kinase 4/6 inhibitors and cardiotoxic events in breast cancer: A pharmacovigilance study based on the FAERS database. International Journal of Cancer, 2024: 1-15. (IF=5.7)

6.Zhao ZN, Fu MY, Li C, Gong ZW, Li T, Ling KX, Li HQY, Li JC, Cao WH, Hong DZ, Hu X, Shi LW, Guan XD, Jin PF*. Prescribing rate, healthcare utilization, and expenditure of older

adults using potentially inappropriate medications in China: A nationwide cross-sectional study. Chinese Medical Journal, 2024; doi: 10.1097/CM9.0000000000003426(IF=7.5)

7.T Jia Huang, Yaru She, Jingyang Yue, Yidu Chen, Yu Li, Jing Li, Yonger Hu , Deying Yang, Jiabo Chen, Lu Yang, Zhongqiu Liu*,Ruibo Wu, Pengfei Jin*, Lixin Duan*. Exploring the catalytic function and active sites of a novel C-glycosyltransferase from Anemarrhena asphodeloides. Synthetic and Systems Biotechnology, 2022, 7: 621–630.( IF=4.8)

8.Pengfei Jin, Xiong Lin, Wenfeng Xu, Kangning Li, Xiaoxiao Zhao, Sirui Guo, Zinan Zhao, Lujie Jiang, Feng Liao, Longgang Chang, Min Wang, Yanmin Liu, Shaolei Huang, Zhangran Chen*, Fusui Ji*. The feasibility of using pathobiome strains as live biotherapeutic products for human use. iMeta, 2024, 3: e202. https://doi.org/ 10.1002/imt2.202. (IF=23.8)

9.Jianchun Li, Weihang Cao, Fei Zhao, Pengfei Jin*. Cost-effectiveness of edaravone dexborneol versus dl-3-n-butylphthalide for the treatment of acute ischemic stroke: a Chinese health care perspective, BMC Public Health, 2024, 2024(24): 436. DOI:10.1186/s12889-024-17959-3(IF=3.5)

10. Chao Li, Kexin Li, Xiaoyu Xu, Wenyuan Qi, Xin Hu, Pengfei Jin*. A Pilot Study for Colorectal Carcinoma Screening by Instant Metabolomic Profiles Using Conductive Polymer Spray Ionization Mass Spectrometry. BBA-Molecular Basis of Disease, 2021, 1867(11): 166210

https://doi.org/10.1016/j.bbadis. 2021.166210 (IF=6.633)

主编或参编的教材、专著（限填10项）

1.全国高级卫生专业技术资格考试指导教材《临床药学》，人民卫生出版社，参编

2.《帕金森病治疗用药风险管理手册》，中国医药科技出版社，主编

专利及其他（限填10项）

1.便携式药物快速筛查仪, 专利, 技术转让, 140.0000万元, 2024-9-8